Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055628/0500 | |
| Pages: | 9 |
| | Recorded: | 03/17/2021 | | |
| Attorney Dkt #: | 10524/006212-US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/29/2023
|
Application #:
|
17204311
|
Filing Dt:
|
03/17/2021
|
|
Publication #:
|
|
Pub Dt:
|
07/22/2021
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING EYE DISEASES, CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TISSUE-PENETRATING PEPTIDE AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PREPARATION ARE FUSED
|
|
|
Assignee
|
|
|
|
|
| (YANGJAE-DONG) 2, BAUMOE-RO 27-GIL, SEOCHO-GU |
| SEOUL, KOREA, REPUBLIC OF 06752 |
|
|
Correspondence name and address
|
| |
LEASON ELLIS LLP
|
| |
ONE BARKER AVENUE
|
| |
FIFTH FLOOR
|
| |
WHITE PLAINS, NY 106011523
|
Search Results as of:
09/23/2024 08:09 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
